SCHEMBL2017798

SCHEMBL2017798

CC(C)(C)OC(=O)N1CCN2c3cc(O)ccc3NC(=O)C[C@@H]2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.42
CRBN Q96SW2 4/20 0.42
USP30 Q70CQ3 2/20 0.40
SMARCA2 P51531 1/20 0.40
SMARCA4 P51532 1/20 0.40
PBRM1 Q86U86 1/20 0.40
PDK1 Q15118 1/20 0.39
PDK2 Q15119 1/20 0.39
PDK3 Q15120 1/20 0.39
PDK4 Q16654 1/20 0.39
DDB1 Q16531 3/20 0.38
BRD4 O60885 2/20 0.37
CREBBP Q92793 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
SRC P12931 2/20 0.37
HDAC6 Q9UBN7 1/20 0.37
ABL1 P00519 1/20 0.37
EGFR P00533 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014200 1.00 ESR2 (0.42) ESR2CRBNUSP30SMARCA2SMARCA4
SCHEMBL2018072 1.00 ESR2 (0.42) ESR2CRBNUSP30SMARCA2SMARCA4
SCHEMBL2015043 0.90 CRBN (0.42) CRBNUSP30SMARCA2SMARCA4PBRM1
SCHEMBL2015044 0.90 CRBN (0.42) CRBNUSP30SMARCA2SMARCA4PBRM1
SCHEMBL2018357 0.89 CNR1 (0.42) CRBNUSP30SMARCA2SMARCA4PBRM1
SCHEMBL2017220 0.89 PAK1 (0.42) CRBNUSP30SMARCA2SMARCA4PBRM1
SCHEMBL2018339 0.89 FPR2 (0.43) CRBNUSP30SMARCA2SMARCA4PBRM1
SCHEMBL2015350 0.87 CRBN (0.40) CRBNUSP30SMARCA2SMARCA4PBRM1
SCHEMBL2017289 0.86 GPR119 (0.45) CRBNUSP30SMARCA2SMARCA4PBRM1
SCHEMBL2013375 0.86 SIGMAR1 (0.45) CRBNUSP30SMARCA2SMARCA4PBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110130382-A1 MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130382-A1 MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF HTR4, HTR1A, HTR1D ESR2 566/4885CRBN 2432/4885USP30 4276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.